Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:HQY 9 January 2026 - 12 January 2026

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity shares fell about 10% Monday after the company issued a cautious initial fiscal 2027 outlook, projecting revenue between $1.38 billion and $1.41 billion and an HSA cash yield near 3.75%. The stock last traded at $84.62, down $9.53. Executives will present at the J.P. Morgan Healthcare Conference on Tuesday. The company reaffirmed its 2026 guidance.
12 January 2026
··
HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity shares dropped 2.9% to $95.64 Friday after Goldman Sachs downgraded the stock to sell and set an $89 target. The move followed HealthEquity’s raised fiscal 2026 revenue outlook and a report of $34.4 billion in HSA assets. KeyBanc maintained an Overweight rating and lifted its price target to $125. The stock fell as the S&P 500 and Nasdaq 100 rose.
9 January 2026
···

Stock Market Today

  • Nifty50 and Sensex End Higher on March 20, 2026; IT, PSU Banks, Metals Lead Gains
    March 20, 2026, 10:02 AM EDT. India's benchmark indices closed higher on March 20, 2026. The BSE Sensex rose 0.44% to 74,533 points, and the NSE Nifty gained 0.49% to 23,114. Strong buying in IT, PSU banks and metal stocks buoyed the market despite fuel price hikes and geopolitical tensions in West Asia. Top gainers included Tech Mahindra (3.30%), Tata Steel (3.29%) and Infosys (2.88%), while Hindalco (-2.55%) and HDFC Bank (-2.23%) led declines. Brent crude oil climbed 1.88% to $110.7 a barrel amid the Israel-Iran conflict. Sector-wise, PSU Bank (+2.19%), IT and metal stocks advanced solidly, but financial services and private banks softened. Market breadth was positive with 2,458 stocks rising, reflecting relief-driven buying amid volatile conditions.
Go toTop